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ABSTRACT 
Conventional medications are expensive and arguably associated with various severe adverse effects, hence the need to develop herbal agents 
that are effective as alternative. Apple (Malus pumila Mill) is the fruit of malus plant. It belongs to the family rosaceae and has been widely 
cultivated in various parts of the world for centuries. It has a beneficial effect on cardiovascular disease, cancer, pulmonary function and age-
related cognitive decline. The leaves of is M. pumila rich in resources, but lack of medicinal value research. Chemical constituents of the same 
family of M. pumila have many activities. This study evaluated the antioxidant and antinociceptive effect of the methanolic extract of M. pumila 
leaves in mice. Qualitative phytochemical screening of methanolic extract was carried out to identify the phytoconstituents.  The In vitro 
antioxidant activity of methanolic extracts of M. pumila leaves was assessed against hydrogen peroxide scavenging assay using standard 
protocols. The antinociceptive activity of methanolic extracts was investigated in thermal-induced (tail immersion) and chemical-induced 
(formalin) nociception models in mice at two different doses (200 and 400 mg/kg; p.o.). Morphine sulphate (10mg/kg, i.p.) was used as 
reference analgesic agents. M. pumila extract demonstrated potent and dose-dependent antinociceptive activity in the chemical and heat 
induced mice models (p < 0.001). The findings of this study indicate that the involvement of both peripheral and central antinociceptive 
mechanisms. Further, the phytochemical screening results showed that the extract had flavonoids, steroids, saponins, phenolics and terpenoids 
which have been associated with anti-nociceptive activities. Therefore, the study has established that the methanolic extracts of M. pumila are 
effective in the management of pain and support the traditional use of this plant in different painful conditions.  
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INTRODUCTION 
Pain is an essential sensation that plays a vital role as a 
body’s natural defence system by alerting us to possible 
tissue injury while nociception is described as the neural 
processes of encoding and processing noxious stimuli that 
usually leads to pain. The process mentioned above is 
initiated by specialized peripheral sensory neurons 
(nociceptors) that are activated by noxious stimuli (i.e., 
mechanical, thermal, and chemical stimuli) due to tissue 
injury and damage, and these nociceptors are usually found 
in the cutaneous tissues, bone, muscle, connective tissues, 
vessels and viscera. These stimuli are transduced into 
electrical impulses (action potentials) that are transmitted 
predominantly through Aδ- and C-fibre nociceptors 
(primary afferent neurons) into the dorsal horn of the spinal 
cord1. A variety of excitatory neurotransmitters are released 
by the primary afferent neurons, such as excitatory amino 
acids, protons, peptides, lipids and cytokines, and others, 
which act on their specific receptors and ion channels, to 
activate the second order neurons of the spinal dorsal horn. 
Once activated, the action potentials are then ascended to 
the thalamus and cerebral cortex through spinothalamic or 
other tracts that lead to perception of pain. Pain can be 
modulated by various analgesic drugs that suppress pain 
signals by acting in various mechanisms on the peripheral 
(PNS) and central nervous system2. However, various 
adverse effects have been reported with these agents. For 
instance, nonsteroidal anti-inflammatory drugs may cause 
gastrointestinal irritation and/or bleeding, decreased 
platelet aggregation (leads to prolong bleeding time), kidney 
damage, edema, bone marrow suppression, rashes, as well 
as anorexia. Opioids, on the other hand, may also lead to 
constipation, dizziness, nausea, respiratory depression, 
sedation, vomiting, as well as physical dependence and 
tolerance with the most being constipation and nausea. 
Hence, there is an imperative need to discover new 
therapies that are more effective and safe with lesser or no 
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side effects. For instance, natural product-based 
medications, particularly plant-derived, are believed to be a 
valuable source of chemical substances that promise to have 
a good potential therapeutic applicability3.  Apple (Malus 
pumila Mill) is the fruit of malus plant. It belongs to the 
family Rosaceae and has been widely cultivated in various 
parts of the world for centuries. At present, the annual global 
apple production is about 70 million tons, thus making apple 
the third largest consumed fruit next to bananas and 
oranges4. Apples contain a relatively high concentration of 
polyphenolics and their consumption has been linked with 
improved health due to their effectiveness in several chronic 
diseases5, 6. Many review articles are available on apple 
products to claim beneficial effects on cardiovascular 
disease, cancer, pulmonary function and age-related 
cognitive decline7,8. Apples are composed of different tissue 
types (peel, cortex, core and seed) and each tissue type 
contains a different composition of phytochemicals9. 
Unpeeled fruits possess higher contents of bioactive 
compounds as compared to peel ones10. Moreover, the 
polyphenolic content of apple peel extract is six times higher 
than that of the fresh extract. The apple fruit pulp contains 
mainly catechin, phloretin glycoside, procyanidins and 
caffeic acid whereas the peel possesses all these compounds 
and has flavonoids such as anthocyanins, quercetin 
glycosides and cyanidin glycoside in addition, which are 
absent in the pulp11. There are reports of beneficial effects of 
apple peel phytochemicals against a variety of 
experimentally induced pathological conditions12. It is 
reported to have an inhibitory effect on low density 
lipoprotein (LDL) oxidation13, anti-proliferative property14, 
depletion of reactive oxygen species (ROS) generation 
during stress conditions15, antihypertensive activity16, a-
glucosidase inhibitory property17 and protective property 
against damaged mitochondria and DNA18. Apple peel has 
also been reported to regulate metastasis19. The oral 
administration of apple extracts has been shown to inhibit 
AP-1 transactivation which involves signal transduction of 
MAP kinase, thus inhibiting cancer formation20. In addition, 
the intake of apple polyphenols is inversely proportional to 
coronary atherosclerosis by inhibition of lipid 
peroxidation21. This study was aimed at bioscreening the 
methanolic leaf extracts of M. pumila for antioxidant and 
antinociceptive activity in mice models, as a preliminary step 
towards development of a more efficacious plant-derived 
antinociceptive agent. 
MATERIALS AND METHODS 
Plant material  
Leaves of M. pumila were collected from Himalaya region 
(Uttarakhand), India. The sample was identified by senior 
Botanist Dr. Zia-Ul-Hassan, Professor and head department 
of Botany, Safia College of Arts and Science, peer gate 
Bhopal. A herbarium of plants was submitted to the 
specimen library of Safia College of Arts and Science, peer 
gate Bhopal and The specimen voucher no. of M. pumila is 
112/Bot/Saf/18.  
Chemical reagents 
All the chemicals used in this study were obtained from 
HiMedia Laboratories Pvt. Ltd. (Mumbai, India), Sigma-
Aldrich Chemical Co. (Milwaukee, WI, USA), SD Fine-Chem. 
Ltd. (Mumbai, India) and SRL Pvt. Ltd. (Mumbai, India).All 
the chemicals used in this study were of analytical grade.  
Extraction  
Dried pulverized leaves of M. pumila were placed in thimble 
of soxhlet apparatus. Soxhlation was performed at 60°C 
using petroleum ether (40-60ºC) as non-polar solvent at 
first. Exhausted plant material (marc) was dried and then 
extracted with methanol. For each solvent, soxhlation was 
continued till no colour was observed in siphon tube. For 
confirmation of exhausted plant marc (i.e. completion of 
extraction), colorless solvent was collected from siphon tube 
and completion of extraction was confirmed by absence of 
any residual solvent, The entire extract was concentrated to 
dryness using rotary flash evaporator under reduced 
pressure and stored in an air tight container free from any 
contamination until it was used. Finally the percentage 
yields were calculated of the dried extracts22.  
Phytochemical screening 
The crude methanolic extract of M. pumila was qualitatively 
tested for the detection of alkaloids, flavonoids, saponins, 
tannins, glycosides, carbohydrates, reducing sugars, 
proteins, glucosides, terpenoids, and steroids following 
standard procedures23. 
Hydrogen peroxide scavenging activity 
Hydrogen peroxide scavenging potential of the plant extract 
was determined using the method described by 
Jayaprakasha et al24 with little modification. A solution of 
hydrogen peroxide (20mM) was prepared in phosphate 
buffer saline (PBS, pH 7.4). Different concentrations of the 
extract (20to100μg/ml) in water (1ml) were added to 2 ml 
of hydrogen peroxide solution in PBS. After 10 min the 
absorbance was measured at 230 nm against a blank 
solution that contained hydrogen peroxide solution without 
the extract. Ascorbic acid was used as positive control. The 
percentage of H2O2 scavenging of the plant extract was 
calculated as follows:  
% scavenged [H2O2] = 
 [(Abs control – Abs sample) / Abs control] × 100 
Animals 
All ethical and handling guidelines were followed as set by 
Indian Legislation and approved by Institutional Animal 
Ethics Committee. All animals were procured and housed in 
animal house maintained under standard hygienic 
conditions. Animal experiments were approved by 
Institutional Animal Ethics Committee (IAEC) of Pinnacle 
Biomedical Research Institute (PBRI) Bhopal (Reg No. 
1824/PO/ERe/S/15/CPCSEA). Protocol Approval Reference 
No. PBRI/IAEC/PN- 1803.  
Acute oral toxicity 
Acute toxicity study of the prepared leaves extracts of M. 
pumila was carried out according to the Organization for 
Economic Co-Operation and Development (OECD) 
Guidelines-42325 the animals were fasted for 4 h, but 
allowed free access to water throughout. Nulliparous healthy 
female mice were used for this study. 3 animals per step 
were selected. Dose selected 5, 50, 300, 2000 mg/kg body 
weight. Immediately after administration of extract, all of the 
animals were observed for a total of 14 days based on 
established criteria, observations of behavior pattern 
changes in skin and eye, respiration, tremors, convulsions, 
salivation, diarrhea, lethargy, sleep and coma. With special 
attention given during the first 4 hours, clinical signs or 
mortality were noted. On day 15, all of the animals were 
euthanized by cervical dislocation. Acute toxicity was 
determined as per reported method26. 
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Antinociceptive activity test 
Formalin test 
The method was used as narrating by Santos and Calixto and 
Santos et al 27,28 with minor modification. The animals were 
arranged into four groups (n = 6). The control group 
received deionized water orally at the volume of 0.1 
ml/mouse 30 min before the experiments. Twenty 
microliters of 2.5% formalin (in deionized water, 
subplantar) was injected subcutaneously into the right hind 
paw 1 h after M. pumila extract treatment (200 and 400 
mg/kg, p.o.) and 15 min after injection of Morphine (10 mg/ 
kg, i.p.) of the mice. The time spent licking and biting the 
injected paw was measured as an indicator of pain response. 
Responses were measured for 5 min subsequent to formalin 
injection (first phase, neurogenic) and 15-30 min after 
formalin injection (second phase, inflammatory). 
Antinociceptive activity was calculated as the percentage 
inhibition of licking time. 
Tail immersion test 
The tail immersion test is based upon the observation that 
morphine-like drugs selectively prolongs the reaction time 
of the typical tail withdrawal reflex in mice. This method was 
used to evaluate the central mechanism of analgesic activity. 
Here, the painful reactions in animals were produced by the 
thermal incentive that is dipping by the tip of the tail in hot 
water29. Mice were divided into four groups consisting of six 
mice in each group. According to the procedure, 5 cm of the 
tail of mice pretreated with morphine (10 mg/kg, i.p.) or M. 
pumila extract (200 and 400 mg/kg, p.o.) were  immersed in 
warm water kept constant at 54 ±1°C. The latency between 
tail submersion and deflection of the tail was recorded. A 
latency period of the 20s was maintained to avoid tail tissue 
damage in mice. The latency period of the tail-withdrawal 
response was taken as the indicator of antinociception and 
was determined at 0, 30, 60, 90, and 120 min after the 
administration of the morphine and M. pumila extract.  
RESULTS AND DISCUSSION 
The crude extracts so obtained after the soxhlation process, 
extract were further concentrated on water bath by 
evaporation the solvents completely to obtain the actual 
yield of extraction. The percentage yield calculated by the 
formula was found to be 0.41 % (by petroleum ether) and 
9.43 % (by methanol). Phytochemical analysis of methanolic 
extract of M. pumila leaves showed the presence of 
carbohydrate, flavonoids, phenolics, tannin, saponins, 
triterpenoids Table 1. 
Table1 Phytochemical analysis of methanolic leaves 
extract of M. pumila 
S. No. Constituents M. pumila 
1. Alkaloids 
Hager’s test 
 
-ve 
2. Flavonoids 
Lead acetate 
Alkaline test 
 
+ve 
+ve 
3. Phenolics 
Fecl3 
 
+ve 
4. Proteins and amino acids 
Xanthoproteic test 
 
+ve 
5. Carbohydrates 
Fehling’s test 
 
+ve 
6. Saponins 
Foam test 
 
-ve 
7. Diterpins 
Copper acetate test 
 
+ve 
8. Glycosides 
Legal’s test 
 
+ve 
9. Tannin and phenolic 
Lead acetate test 
 
+ve 
 
10 Carbohydrates 
Fehling’s test 
 
+ve 
 
As shown in Table 2, M. pumila leaf extract demonstrated 
hydrogen peroxide decomposition activity in a 
concentration dependent manner with an IC50 of 17.95, 
38.06µg/ml. Scavenging activity of H2O2 by the extract may 
be attributed to their phenolics, which can donate electrons 
to H2O2 thereby neutralizing it into water30. 
 
Table 2 % Inhibition of ascorbic acid and methanolic extract of M. pumila using hydrogen peroxide scavenging assay 
method 
S. No. Concentration 
(µg/ml) 
Ascorbic acid  
% Inhibition 
M. pumila  
% Inhibition 
1. 20 51.47808 44.34251 
2. 40 56.88073 49.43935 
3. 60 62.69113 58.10398 
4. 80 70.33639 64.8318 
5. 100 77.47197 69.72477 
 IC50 17.95 38.06 
 
Acute oral toxicity was calculated at four different concentrations 5mg/kg, 50mg/kg, 300 mg/kg and 2000 mg/kg. Observations 
were performed in groups of three and no mortality was observed Table 3.  
Table 3 Acute oral toxicity 
S. No. Groups Observations/Mortality 
1. 5 mg/kg Bodyweight 0/3 
2. 50 mg/kg Bodyweight 0/3 
3. 300 mg/kg Bodyweight 0/3 
4. 2000 mg/kg Bodyweight 0/3 
Sable et al                                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(4-A):632-636  
ISSN: 2250-1177                                                                                  [635]                                                                                 CODEN (USA): JDDTAO 
The acute toxicity results showed that methanolic extracts of 
M. pumila was safe up to a dose of 2000 mg/kg body weight. 
Based on acute toxicity data, two different dosages 200 and 
400 mg/kg (p.o.) were selected for in vivo anti-nociceptive 
activity. M. pumila  leaf extract produced a dose-related 
inhibition of formalin induced nociception and caused 
significant inhibition of both neurogenic (0-5 min) and 
inflammatory (15-30 min) phases of formalin-induced 
licking test at the doses of 200 and 400 mg/kg when 
compared with control group (Deionized water) (Table 4). 
However, its antinociceptive effect was more pronounced in 
the second phase of this model of pain. Morphine (10 mg/kg, 
i.p.) significantly reduced formalin induced nociception in 
both phases (p < 0.001). In formalin-induced paw licking test 
M. pumila has shown the ability to affect both the early and 
late phase inflammatory effects of the formalin test, which 
implies the involvement of not only the central mechanism 
but also the peripheral antinociceptive activity of the extract. 
The early phase, classified as neurogenic pain, is an acute 
response observed immediately after the administration of 
formalin and is due to direct action of injected formalin on 
nociceptors. While the late phase, classified as an 
inflammatory pain, is a late response resulting from the 
inflammatory processes generated by the release of 
inflammatory mediators such as histamine, serotonin, 
prostaglandins and bradykinin, and activation of the 
neurons in the dorsal horns of the spinal cord31. Both phases 
have their own characteristics that can be used as tool to 
assess the antinociceptive potential as well as to elucidate 
the mechanisms of antinociception. The early phase 
represents a direct irritant effect of formalin on sensory 
fibers, while the late phase represents response secondary 
to the development of inflammatory process and the release 
of inflammatory mediators32. It has been reported that drugs 
acting centrally (i.e. narcotics/opioids) inhibit both phases 
of the formalin test while those acting peripherally (i.e. 
NSAIDs) inhibit only the late phase, respectively33,34. 
Therefore, the results shown by M. pumila suggest that the 
extract contains bioactive compound(s) with central and 
peripheral antinociceptive actions and additional anti-
inflammatory activity31. The ability of M. pumila to inhibit 
chemically- and thermally-induced nociceptive processes 
tested in this study presents its potential to be used as an 
analgesic agent.  The tail-immersion test results asserted 
significant antinociceptive effect (p < 0.001) compared with 
control, at the doses of 200 and 400mg/kg. The 
antinociceptive effect of 200 and 400 mg/kg of M. pumila 
leaf extract were comparable to that of the reference drug 
(Table 5). A significant antinociceptive effect was produced 
by morphine (p < 0.001) when compared with control group 
(Deionized water). Tail immersion model is considered as an 
acute pain model. The tail-withdrawal response of mice is 
predominantly considered to be selective for centrally acting 
analgesics, whereas the peripherally acting drugs are known 
to be inactive on such heat-induced pain response35. The 
significant increase (p<0.05) in tail-withdrawal time by the 
extract suggests the involvement of central mechanisms in 
its antinociceptive effect. Tail immersion monitors a spinal 
reflex involving μ2- and δ-opioid receptors36. Therefore, the 
results of the present study indicate that the central 
antinociceptive effect of M. pumila may be prominent on μ-
opioid receptors. 
 
Table 4 Antinociceptive effect of M. pumila extract and morphine in formalin-induced paw licking test 
S.N0. Treatment 
groups 
Mean lick time (sec) ± SD 
Early Phase Late Phase 
1 Control 102 ± 4.358 240.5±26.113 
2 Morphine 28.5 ± 3.593 37.16±2.339 
3 Extract 200 82.5 ± 4.958 132 ±3.696 
4 Extract 400 35.66 ± 2.94 45.33±3.543 
 
Table 5 Antinociceptive effect of M. pumila extract and morphine in tail immersion test 
S.N0. Treatment 
groups 
Latency period (s) (% 
MPE) Pretreatment 
60 min 90 min 120min 150 min 
1 Control 1.33± 0.74 1.5± 0.5 1.66±0.74 1.25±0.901 1.8±0.786 
2 Morphine 3.16±0.68 36.16± 4.41 40.16±4.59 41.33± 3.63 37.83± 3.23 
3 Extract 200 0.816±0.81 8.5 ± 0.763 15.16± 2.26 20 ± 2.08 15± 1.41 
4 Extract 400 1.83±0.37 16.33± 1.24 20.0 ± 1.29 35.83± 2.40 22.83± 1.34 
 
 
CONCLUSIONS 
M. Pumila has recently received some attention for its 
beneficial effects against several diseases. Our research 
study showed that the use of M. Pumila could effectively 
reduce the severity of pain. It can be concluded that M. 
Pumila possesses significant antinociceptive activity in both 
chemical and heat induced pain models in mice. The 
antinociceptive effect of M. Pumila is most likely mediated 
via inhibition of peripheral mediators and central inhibitory 
mechanisms. These results support the traditional use of this 
plant in different painful conditions. Further investigations 
are required to perceive the mechanisms of action of M. 
Pumila extract and to identify the active constituents that 
may be used as a lead compound for new drug development.   
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